Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

IMMUNE RESPONSE RAISES $44 MILLION

Oct. 30, 1991

GENENTECH SEEKS BUYER FOR GLC ASSOCIATES

Oct. 30, 1991

XOMA WILL TRY TO BLOCK CENTOXIN

Oct. 30, 1991

GLAXO, AMYLIN TO CO-DEVELOP DIABETES DRUGS

Oct. 30, 1991

JURY RULES FOR XOMA IN PATENT DISPUTE

Oct. 29, 1991

GENENTECH WINS MARKET EXCLUSIVITY IN JAPAN

Oct. 29, 1991

LEGAL WOES CONTRIBUTE TO COLLAGEN LOSS

Oct. 29, 1991

GENZYME REPORTS PROFITABLE QUARTER

Oct. 29, 1991

QUEST TO PRODUCE ESCAGENETICS FLAVORINGS

Oct. 29, 1991

FDA CLEARS BAINBRIDGE'S H. PYLORI TEST

Oct. 29, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...